Attention-deficit/hyperactivity disorder rating scale IV subscale analysis by visit in a European, phase 3, randomized, double-blind clinical trial of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity deficit

被引：0
|
作者：
Huss, M.
Johnson, M.
Mcnicholas, F.
Van Stralen, J.
Dirks, B.
Adeyi, B.
Hervas, A.
机构：
[1] Univ Gothenberg, Univ Mainz, Mainz, Germany
[2] Our Ladys Childrens Hosp, Dublin, Ireland
[3] Ctr Pediat Excellence, Boston, MA USA
[4] Shire, Dublin, Ireland
[5] Univ Hosp Mutua De Terrassa, Barcelona, Spain
来源：
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
PS-012
引用
收藏
页码：S133 / S134
页数：2
相关论文
共 50 条
  • [31] Managing Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    McClain, Elizabeth K.
    Burks, Erin Jewell
    PRIMARY CARE, 2015, 42 (01): : 99 - +
  • [32] ATTENTION-DEFICIT HYPERACTIVITY DISORDER - AIDS IN CHILDREN AND ADOLESCENTS
    ALGER, I
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1989, 40 (12): : 1222 - 1223
  • [33] Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Storebo, Ole J.
    Simonsen, Erik
    Gluud, Christian
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (18): : 2009 - 2010
  • [34] Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: A randomized, controlled, Phase III trial
    Hervas, Amaia
    Huss, Michael
    Johnson, Mats
    McNicholas, Fiona
    van Stralen, Judy
    Sreckovic, Sasha
    Lyne, Andrew
    Bloomfield, Ralph
    Sikirica, Vanja
    Robertson, Brigitte
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (12) : 1861 - 1872
  • [35] EXTENDED-RELEASE GUANFACINE HYDROCHLORIDE IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, PHASE 3 RANDOMIZED WITHDRAWAL STUDY
    Huss, M.
    Newcorn, J.
    Harpin, V.
    Johnson, M.
    Ramos-Quiroga, J.
    van Stralen, J.
    Dutray, B.
    Sreckovic, S.
    Lyne, A.
    Bloomfield, R.
    Sikirica, V.
    Naser, N.
    Robertson, B.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2015, 49 : 111 - 112
  • [36] Guanfacine extended release: daytime sleepiness outcomes from a phase 3 clinical study in adolescents with attention-deficit/hyperactivity disorder
    Cutler, A.
    Harper, L.
    Young, J.
    Adeyi, B.
    Dirks, B.
    Wilens, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S648 - S649
  • [37] GUANFACINE EXTENDED RELEASE IN THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS
    Connor, D. F.
    Rubin, J.
    DRUGS OF TODAY, 2010, 46 (05) : 299 - 314
  • [38] A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder
    Spencer, T
    Biederman, J
    Wilens, T
    Doyle, R
    Surman, C
    Prince, J
    Mick, E
    Aleardi, M
    Herzig, K
    Faraone, S
    BIOLOGICAL PSYCHIATRY, 2005, 57 (05) : 456 - 463
  • [39] Long-Term Safety and Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Sallee, Floyd R.
    Lyne, Andrew
    Wigal, Timothy
    McGough, James J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (03) : 215 - 226
  • [40] Long-term safety and efficacy of guanfacine extended release in children and adolescents with Attention-Deficit/Hyperactivity disorder
    Sallee, Floyd
    McGough, James J.
    Wigall, Timothy
    Farrand, Kimberly
    Lyne, Andrew
    Biederman, Joseph
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 247S - 247S
12345